Literature DB >> 2546160

Transgenic mouse model for human gastric carcinoma.

K Koike1, S H Hinrichs, K J Isselbacher, G Jay.   

Abstract

To understand the pathogenesis that may be induced by human adenovirus type 12 (Ad12), we have generated transgenic mice carrying the Ad12 early region 1 under control of the mouse mammary tumor virus long terminal repeat. Eleven of 11 male founder mice, but only 2 of 12 females, died between 3 to 4 mo of age. Death was associated with presence of tumors at or near the squamocolumnar junction of the stomach. Microscopically, these multifocal tumors appeared to arise from hyperplastic epithelium and showed features consistent with adenocarcinoma or adenosquamous carcinoma. High levels of expression of both the Ad12 E1A and E1B genes were seen in the tumor-bearing stomach. Various levels of expression were also detected in other tissues, although the stomach was the only organ with detectable pathology. These observations suggest an organ-specific action of the Ad12 early region 1 gene products. This transgenic mouse model provides an experimental system for studying the development of human carcinomas at sites of transition from squamous to columnar epithelium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546160      PMCID: PMC297673          DOI: 10.1073/pnas.86.14.5615

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Susceptibility of teratocarcinoma cells to adenovirus type 2.

Authors:  F Kelly; M Boccara
Journal:  Nature       Date:  1976-07-29       Impact factor: 49.962

2.  Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumour virus chimaeric plasmids.

Authors:  F Lee; R Mulligan; P Berg; G Ringold
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

3.  Malignant transformation of human embryo retinoblasts by cloned adenovirus 12 DNA.

Authors:  P Byrd; K W Brown; P H Gallimore
Journal:  Nature       Date:  1982-07-01       Impact factor: 49.962

4.  Characterization of cells transformed by Ad5/Ad12 hybrid early region I plasmids.

Authors:  R Bernards; A Houweling; P I Schrier; J L Bos; A J Van der Eb
Journal:  Virology       Date:  1982-07-30       Impact factor: 3.616

5.  Mechanism of activation of early viral transcription by the adenovirus E1A gene product.

Authors:  J R Nevins
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

6.  Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA.

Authors:  A Houweling; P J van den Elsen; A J van der Eb
Journal:  Virology       Date:  1980-09       Impact factor: 3.616

7.  A study of the oncogenicity of adenovirus type 2 transformed rat embryo cells.

Authors:  L M Harwood; P H Gallimore
Journal:  Int J Cancer       Date:  1975-09-15       Impact factor: 7.396

8.  In vitro traits of adenovirus-transformed cell lines and their relevance to tumorigenicity in nude mice.

Authors:  P H Gallimore; J K McDougall; L B Chen
Journal:  Cell       Date:  1977-04       Impact factor: 41.582

9.  The E1b promoter of Ad12 in mouse L tk- cells is activated by adenovirus region E1a.

Authors:  J L Bos; H C ten Wolde-Kraamwinkel
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  IMMUNOFLUORESCENT STUDIES OF ADENOVIRUS 12 TUMORS AND OF CELLS TRANSFORMED OR INFECTED BY ADENOVIRUSES.

Authors:  J H POPE; W P ROWE
Journal:  J Exp Med       Date:  1964-10-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Expression and interactions of human adenovirus oncoproteins.

Authors:  P A Boulanger; G E Blair
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

Review 2.  Expression of activated oncogenes in the murine mammary gland: transgenic models for human breast cancer.

Authors:  W J Muller
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

3.  Adenovirus 12 E1A gene detection by polymerase chain reaction in both the normal and coeliac duodenum.

Authors:  M Lawler; P Humphries; C O'Farrelly; H Hoey; O Sheils; M Jeffers; D S O'Briain; D Kelleher
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

4.  Transgenic mouse model for central nervous system demyelination.

Authors:  T Yoshioka; L Feigenbaum; G Jay
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

5.  Activation of retrovirus in transgenic mice: association with development of olfactory neuroblastoma.

Authors:  K Koike; G Jay; J W Hartley; M D Schrenzel; R J Higgins; S H Hinrichs
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

6.  Serial observations on an orthotopic gastric cancer model constructed using improved implantation technique.

Authors:  Yan Li; Bo Li; Yu Zhang; Chun-Ping Xiang; Yuan-Yuan Li; Xiao-Ling Wu
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

7.  Characterization of gastric cancer models from different cell lines orthotopically constructed using improved implantation techniques.

Authors:  Yan Li; Bo Li; Chun-Ping Xiang; Yu Zhang; Yuan-Yuan Li; Xiao-Ling Wu
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

8.  Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts.

Authors:  K Koike; K Moriya; H Yotsuyanagi; S Iino; K Kurokawa
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

9.  Very high incidence of germ cell tumorigenesis (seminomagenesis) in human papillomavirus type 16 transgenic mice.

Authors:  G Kondoh; Y Murata; K Aozasa; M Yutsudo; A Hakura
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

10.  Expression pattern of mouse mammary tumor virus in transgenic mice carrying exogenous proviruses of different origins.

Authors:  P Rollini; J Billotte; E Kolb; H Diggelmann
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.